Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seegene has established itself as a global leader in molecular diagnostics with a broad commercial portfolio of multiplex PCR assays for infectious disease detection. The company played a significant role during the COVID‑19 pandemic by rapidly developing and distributing SARS-CoV‑2 tests. Its products are widely used for early diagnosis of various infectious and genetic diseases. Recent financial results show record-high revenues driven by both COVID-related products and expansion into non-COVID diagnostic areas such as HPV and STI testing. The company continues to invest heavily in R&D to expand its automated platforms and syndromic assay offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seegene.